NEW YORK ─ The Foundation for Innovative New Diagnostics (FIND) and Unitaid on Friday announced that they have finalized the first among a set of agreements that will enable more than 250 million rapid antigen tests (Ag RDTs) per year to be made available for low- and middle-income countries (LMICs) for a unit price of less than $2.50 apiece.